BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Corcept, Clovis Score Wins in Advanced Ovarian Cancer

  It’s a promising day for advanced ovarian cancer research as two biopharma companies achieved positive results. Here’s what you need to know about research.

  March 31, 2022

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Rani is Opening Doors in Biosimilars, Challenging Humira and Others

  San Jose-based Rani Therapeutics reported its fourth quarter and full-year 2021 financial results. The company hit major milestones this year, including the recent launch of the RaniPill High Capacity,

  March 31, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Dr. Arthur Riggs Leaves a Legacy in Biotech, Diabetes Research

  The man who many consider the father of synthetic insulin treatment for diabetes, as well as a founder of modern biotechnology- Dr. Arthur Riggs - died this week at the age of 82.

  March 31, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Medical Advocacy and Ingenuity of the Human Spirit are Curing Disease

  When Sekar Kathiresan’s brother unexpectedly died from a heart attack, he changed the course of his life to found a company with a novel medicine that may prevent them.

  March 31, 2022

   · 

  7 min read

   · 

  Abbey Glasure
• 

  Business

  Workforce Cuts Abound at Zealand Pharma, Merck and Orchard

  Several employees at three biopharma firms are not having a very good week, as Zealand Pharma, Merck and Orchard Therapeutics all announced job cuts.

  March 31, 2022

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  A “Prime” Time Genetic Medicine Deal for Cancer and Autoimmune Therapies

  Myeloid Therapeutics has signed an exclusive collaboration deal with Prime Medicine to leverage both companies’ technologies and discover cancer and autoimmune diseases treatments.

  March 31, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Narrowing Focus to Rett and GAN, Taysha is Reducing Workforce by 35%

  Taysha Gene Therapies announced that it will focus its efforts on clinical programs targeting Rett Syndrome and giant axonal neuropathy (GAN), resulting in a 35% reduction in its workforce.

  March 31, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  With Positive Phase II Results, Cerevance Proves Concept in Parkinson’s

  Cerevance reported positive clinical trial results for CVN424, an experimental treatment for Parkinson’s disease.

  March 31, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Origami Brings Protein Degradation to Neurodegenerative Disorders

  Origami’s precision technology platform, Oricision™, is focused on diseases that affect the central nervous system rather than oncology.

  March 31, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  CytoDyn Hit with Two Clinical Holds as Optimism Appears to Wane

  The U.S. FDA placed a partial hold on CytoDyn’s HIV program and a full clinical hold on its COVID-19 program in the U.S.

  March 31, 2022

   · 

  3 min read

   · 

  Mark Terry